Patent · US Active

Anti-tumor drug, medicament, composition, and use thereof

US8372810B2 · kind B2 · utility

0Cited by

2References

25Claims

0Family size

Assignee

GENE SIGNAL INTERNATIONAL SA · CH

Inventors

Sylvie Colin · Paris, FR
Salman Al Mahmood · Paris, FR

Key dates

Filing date	Apr 11, 2008
Grant date	Feb 12, 2013
Priority date	—
Expiry date	Jul 15, 2029

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P35/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to an active polypeptide including the amino acid sequence of SEQ ID NO:3, or having at least 50%, preferably 70%, more preferably 90% identity with the amino acid sequence of SEQ ID NO:3, or fragments thereof having at least 21 contiguous amino acids, or peptides having at least 50%, preferably 70%, more preferably 90% identity with the amino acid sequence of the fragments, provided that the polypeptide is not SEQ ID NO:2, variants and antigenic fragments thereof, SEQ ID NO 16 or SEQ ID NO 17, and uses thereof in a method of treating cancer and/or tumours of the human or animal body.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.